Risk of ophthalmic adverse drug reactions in patients prescribed glucagon-like peptide 1 receptor agonists: a pharmacovigilance study based on the FDA adverse event reporting system database
DOI:
10.1007/s12020-024-04112-8
Publication Date:
2024-11-22T20:54:19Z
AUTHORS (6)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (33)
CITATIONS (4)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....